Efficacy and safety of etrasimod, a sphingosine 1‐phosphate receptor modulator, in adults with moderate‐to‐severe atopic dermatitis (<scp>ADVISE</scp>)

I. Silverberg, Jonathan; Bissonnette, Robert; Kircik, Leon; F. Murrell, Dédée; Selfridge, Andrew; Liu, Kris; S. Ahluwalia, Gurpreet; Guttman‐Yassky, Emma

doi:10.1111/jdv.18914

Public

Efficacy and safety of etrasimod, a sphingosine 1‐phosphate receptor modulator, in adults with moderate‐to‐severe atopic dermatitis (ADVISE)

Published in Journal of the European Academy of Dermatology and Venereology • Jan 25, 2023

Authors:

Jonathan I. Silverberg

Robert Bissonnette

Leon Kircik

Abstract

BACKGROUND: modulator in development for immune-mediated inflammatory disorders. Efficacy and safety of orally administered S1P receptor modulation in atopic dermatitis (AD) have not yet been examined. OBJECTIVE: To assess the efficacy and safety of etrasimod monotherapy in adults with moderate-to-s...

Subject

Medicine

Eczema Area and Severity Index

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!